— Know what they know.
Not Investment Advice
Also trades as: GLPG.BR (BRU)

GLPG NASDAQ

Galapagos N.V.
1W: -1.2% 1M: -1.4% 3M: -16.2% YTD: -15.1% 1Y: -2.3% 3Y: -33.6% 5Y: -63.4%
$27.98
Last traded 2026-06-04 — delisted
NASDAQ · Healthcare · Biotechnology · $1.8B mcap · 45M float · 0.344% daily turnover · Short 67% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$1.1B +303.5% ▲
5Y CAGR: +18.4%
Gross Profit
$990M +311.1% ▲
Operating Income
$451M +339.5% ▲
Net Income
$321M +333.2% ▲
EPS (Diluted)
$4.85 +333.0% ▲
EBITDA
$557M +1185.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$485M$241M$240M$276M$1.1B
YoY Growth+1.4%-50.2%-0.6%+15.0%+303.5%
Cost of Revenue$2M$0$0$35M$489M
Gross Profit$483M$241M$240M$241M$990M
Gross Margin99.7%100.0%100.0%87.4%89.0%
R&D Expenses$492M$270M$241M$335M$459M
SG&A Expenses$167M$103M$94M$97M$153M
Operating Expenses$649M$372M$328M$429M$328M
Operating Income-$166M-$131M-$88M-$188M$451M
Operating Margin-34.2%-54.3%-36.8%-68.3%40.6%
Interest Expense$12M$9M$2M$911K$3M
Income Before Tax-$123M-$71M$6M-$3M$289M
Tax Expense$2M$572K$10M-$2M-$18M
Net Income-$125M-$218M$212M$74M$321M
Net Margin-25.9%-90.4%88.3%26.9%28.9%
EPS (Diluted)$-1.91$-3.32$-0.06$1.12$4.85
EBITDA-$101M$4M$51M$43M$557M
Shares Outstanding66M66M66M66M66M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms